Following the presentation of first-in-human cases with the GECKO system at the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September, Nice, France),
Basecamp Vascular – BCV CEO & Co-founder Raphaël Blanc (Foundation Rothschild Hospital, Paris, France) spoke to NeuroNews to discuss this technology. In this video, Raphaël Blanc also outlines potential directions the company may take in the future,
BCV Chief Technology Officer & Co-founder Jean-Baptiste Cazeneuve provides a live demonstration with the device—a steerable mechatronic guidewire intended for use in neurovascular stroke treatments.